Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency

J Allergy Clin Immunol Pract. 2022 Jul;10(7):1903-1906. doi: 10.1016/j.jaip.2022.01.012. Epub 2022 Jan 29.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Eosinophilia* / drug therapy
  • Humans
  • Hypersensitivity*
  • Inflammation
  • Transforming Growth Factor beta

Substances

  • Transforming Growth Factor beta